Digital Respiratory Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

Description

The Digital Respiratory Devices Market report by Persistence Market Research provides an in-depth analysis of market dynamics, growth factors, challenges, and emerging trends from 2024 to 2032. It offers insights into the current state and future outlook of the Digital Respiratory Devices Market.

The global digital respiratory devices market is projected to grow at a compound annual growth rate (CAGR) of 25% from USD 67.19 billion in 2024 to USD 400 billion by 2032.

Key Insights:

Estimated Market Size (2024): USD 67.19 Billion
Projected Market Size (2032): USD 400 Billion
Global Market Growth Rate (CAGR 2024 to 2032): 25%

Digital Respiratory Devices Market - Report Scope:

Digital respiratory devices encompass a range of technology-enabled solutions used in the management and treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. The report outlines key drivers behind the increasing adoption of digital respiratory devices, including advancements in sensor technology, telemedicine, and remote patient monitoring.

Market Growth Drivers:

The market's growth is driven by several factors. Firstly, the rising prevalence of respiratory diseases, including asthma, COPD, and obstructive sleep apnea, globally, fuels demand for digital respiratory devices for early detection, monitoring, and management of these conditions. Additionally, technological advancements in digital health solutions, including wearable sensors, mobile apps, and connected devices, enable real-time monitoring of respiratory parameters such as lung function, oxygen saturation, and respiratory rate, empowering patients and healthcare providers with actionable insights for personalized treatment strategies and timely interventions. Moreover, the growing emphasis on preventive care, patient engagement, and self-management in respiratory disease management drives adoption of digital respiratory devices, facilitating remote monitoring, teleconsultations, and virtual care delivery models, particularly in underserved and remote healthcare settings.

Market Restraints:

Despite the positive outlook, the Digital Respiratory Devices Market faces certain challenges. Factors such as data privacy concerns, interoperability issues, and regulatory barriers may impede widespread adoption and integration of digital respiratory devices into existing healthcare ecosystems, limiting their utility and scalability. Moreover, disparities in healthcare access, digital literacy, and socioeconomic status may exacerbate inequalities in respiratory disease management and exacerbation prevention, hindering market penetration and adoption rates of digital respiratory devices among marginalized populations. Additionally, reimbursement limitations, healthcare reimbursement policies, and coverage restrictions for digital health technologies may impact market dynamics, investment decisions, and commercialization strategies for digital respiratory devices, posing challenges to market growth and sustainability.

Market Opportunities:

The Digital Respiratory Devices Market offers significant opportunities for innovation and market expansion. Manufacturers and developers can focus on developing user-friendly, cost-effective digital respiratory devices with enhanced features such as wireless connectivity, cloud-based data analytics, and artificial intelligence algorithms for predictive analytics and personalized care recommendations. For instance, smart inhalers equipped with sensors and Bluetooth connectivity enable real-time tracking of medication adherence, inhaler technique, and environmental triggers, enhancing treatment adherence, inhaler technique, and asthma control in patients with respiratory conditions. Moreover, strategic collaborations, partnerships, and pilot projects with healthcare providers, payers, and technology partners facilitate market access, validation, and adoption of digital respiratory devices in clinical practice, home healthcare, and telemedicine applications. Furthermore, investments in research and development, clinical validation, and regulatory compliance enable companies to address unmet needs, demonstrate clinical efficacy, and gain regulatory approvals for digital respiratory devices, driving market differentiation and competitive advantage in the global digital respiratory devices market.

Key Questions Addressed in the Report:

What is the Expected CAGR of the Digital Respiratory Devices Market from 2024 to 2032?
What are the Key Factors Driving the Growth of the Digital Respiratory Devices Market?
Which Type of Digital Respiratory Device Holds the Largest Market Share?
Who are the Key Players in the Global Digital Respiratory Devices Market?
What Strategies are Adopted by Leading Companies to Stay Competitive in the Digital Respiratory Devices Market?

Competitive Landscape and Business Strategies:

Key players in the Digital Respiratory Devices Market include Propeller Health (a ResMed Company), Adherium Limited, Teva Pharmaceuticals Industries Ltd., Cohero Health, and NuvoAir, among others. These companies focus on product innovation, strategic partnerships, and market expansion to maintain a competitive edge in the market. For instance, Propeller Health offers a range of digital health solutions for asthma and COPD management, including sensor-enabled inhaler devices, mobile apps, and population health analytics platforms, while Adherium Limited specializes in smart medication adherence solutions for respiratory diseases. Market players also invest in clinical trials, real-world evidence generation, and regulatory approvals to demonstrate clinical efficacy, safety, and value proposition of digital respiratory devices, fostering adoption by healthcare providers, payers, and patients in the global market.

Key Companies Profiled:

COHERO Health Inc.
Cognita Labs
Adherium limited
Amiko Digital Health Limited
Teva pharmaceuticals industries Ltd.
Propeller Health
Novartis AG
Pneuma Respiratory Inc.
3m Health Care Limited
AireHealth, Inc.

Digital Respiratory Devices Market Segmentation:

By Product

Smart Inhalers & Nebulizers
Sensors & Apps

By Indication

Asthma
COPD
Other Diseases

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By End Use

Hospitals
Homecare Settings
Other settings

By Region

North America
Europe
East Asia
South Asia
Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33183

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter's Analysis
3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
3.7. Regional Parent Market Outlook

4. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast, 2024-2032

4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis

5. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Product

5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2032
- 5.3.1. Smart inhalers & Nebulizers
- 5.3.2. Sensors & Apps
5.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
5.5. Absolute $ Opportunity Analysis By Product, 2024-2032

6. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Indication

6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2019-2023
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2024-2032
- 6.3.1. Asthma
- 6.3.2. COPD
- 6.3.3. Other Diseases
6.4. Y-o-Y Growth Trend Analysis By Indication, 2019-2023
6.5. Absolute $ Opportunity Analysis By Indication, 2024-2032

7. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By End-Use

7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By End-Use , 2019-2023
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-Use , 2024-2032
- 7.3.1. Hospitals
- 7.3.2. Homecare Settings
- 7.3.3. Other settings
7.4. Y-o-Y Growth Trend Analysis By End-Use , 2019-2023
7.5. Absolute $ Opportunity Analysis By End-Use , 2024-2032

8. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Distribution Channel

8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2019-2023
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2032
- 8.3.1. Hospital Pharmacies
- 8.3.2. Retail Pharmacies
- 8.3.3. Online Pharmacies
8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019-2023
8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024-2032

9. Global Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Region

9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
- 9.3.1. North America
- 9.3.2. Latin America
- 9.3.3. Europe
- 9.3.4. South Asia
- 9.3.5. East Asia
- 9.3.6. Oceania
- 9.3.7. MEA
9.4. Market Attractiveness Analysis By Region

10. North America Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
- 10.2.1. By Country
  - 10.2.1.1. U.S.
  - 10.2.1.2. Canada
- 10.2.2. By Product
- 10.2.3. By Indication
- 10.2.4. By End-Use
- 10.2.5. By Distribution Channel
10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By Indication
- 10.3.4. By End-Use
- 10.3.5. By Distribution Channel
10.4. Key Takeaways

11. Latin America Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
- 11.2.1. By Country
  - 11.2.1.1. Brazil
  - 11.2.1.2. Mexico
  - 11.2.1.3. Rest of Latin America
- 11.2.2. By Product
- 11.2.3. By Indication
- 11.2.4. By End-Use
- 11.2.5. By Distribution Channel
11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Product
- 11.3.3. By Indication
- 11.3.4. By End-Use
- 11.3.5. By Distribution Channel
11.4. Key Takeaways

12. Europe Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
- 12.2.1. By Country
  - 12.2.1.1. Germany
  - 12.2.1.2. U.K.
  - 12.2.1.3. France
  - 12.2.1.4. Spain
  - 12.2.1.5. Italy
  - 12.2.1.6. Rest of Europe
- 12.2.2. By Product
- 12.2.3. By Indication
- 12.2.4. By End-Use
- 12.2.5. By Distribution Channel
12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Product
- 12.3.3. By Indication
- 12.3.4. By End-Use
- 12.3.5. By Distribution Channel
12.4. Key Takeaways

13. South Asia Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
- 13.2.1. By Country
  - 13.2.1.1. India
  - 13.2.1.2. Malaysia
  - 13.2.1.3. Singapore
  - 13.2.1.4. Thailand
  - 13.2.1.5. Rest of South Asia
- 13.2.2. By Product
- 13.2.3. By Indication
- 13.2.4. By End-Use
- 13.2.5. By Distribution Channel
13.3. Market Attractiveness Analysis
- 13.3.1. By Country
- 13.3.2. By Product
- 13.3.3. By Indication
- 13.3.4. By End-Use
- 13.3.5. By Distribution Channel
13.4. Key Takeaways

14. East Asia Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
- 14.2.1. By Country
  - 14.2.1.1. China
  - 14.2.1.2. Japan
  - 14.2.1.3. South Korea
- 14.2.2. By Product
- 14.2.3. By Indication
- 14.2.4. By End-Use
- 14.2.5. By Distribution Channel
14.3. Market Attractiveness Analysis
- 14.3.1. By Country
- 14.3.2. By Product
- 14.3.3. By Indication
- 14.3.4. By End-Use
- 14.3.5. By Distribution Channel
14.4. Key Takeaways

15. Oceania Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
- 15.2.1. By Country
  - 15.2.1.1. Australia
  - 15.2.1.2. New Zealand
- 15.2.2. By Product
- 15.2.3. By Indication
- 15.2.4. By End-Use
- 15.2.5. By Distribution Channel
15.3. Market Attractiveness Analysis
- 15.3.1. By Country
- 15.3.2. By Product
- 15.3.3. By Indication
- 15.3.4. By End-Use
- 15.3.5. By Distribution Channel
15.4. Key Takeaways

16. MEA Digital Respiratory Devices Market Analysis 2019-2023 and Forecast 2024-2032, By Country

16.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
16.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
- 16.2.1. By Country
  - 16.2.1.1. GCC Countries
  - 16.2.1.2. South Africa
  - 16.2.1.3. Israel
  - 16.2.1.4. Rest of MEA
- 16.2.2. By Product
- 16.2.3. By Indication
- 16.2.4. By End-Use
- 16.2.5. By Distribution Channel
16.3. Market Attractiveness Analysis
- 16.3.1. By Country
- 16.3.2. By Product
- 16.3.3. By Indication
- 16.3.4. By End-Use
- 16.3.5. By Distribution Channel
16.4. Key Takeaways

17. Key Countries Digital Respiratory Devices Market Analysis

17.1. U.S.
- 17.1.1. Pricing Analysis
- 17.1.2. Market Share Analysis, 2023
  - 17.1.2.1. By Product
  - 17.1.2.2. By Indication
  - 17.1.2.3. By End-Use
  - 17.1.2.4. By Distribution Channel
17.2. Canada
- 17.2.1. Pricing Analysis
- 17.2.2. Market Share Analysis, 2023
  - 17.2.2.1. By Product
  - 17.2.2.2. By Indication
  - 17.2.2.3. By End-Use
  - 17.2.2.4. By Distribution Channel
17.3. Brazil
- 17.3.1. Pricing Analysis
- 17.3.2. Market Share Analysis, 2023
  - 17.3.2.1. By Product
  - 17.3.2.2. By Indication
  - 17.3.2.3. By End-Use
  - 17.3.2.4. By Distribution Channel
17.4. Mexico
- 17.4.1. Pricing Analysis
- 17.4.2. Market Share Analysis, 2023
  - 17.4.2.1. By Product
  - 17.4.2.2. By Indication
  - 17.4.2.3. By End-Use
  - 17.4.2.4. By Distribution Channel
17.5. Germany
- 17.5.1. Pricing Analysis
- 17.5.2. Market Share Analysis, 2023
  - 17.5.2.1. By Product
  - 17.5.2.2. By Indication
  - 17.5.2.3. By End-Use
  - 17.5.2.4. By Distribution Channel
17.6. U.K.
- 17.6.1. Pricing Analysis
- 17.6.2. Market Share Analysis, 2023
  - 17.6.2.1. By Product
  - 17.6.2.2. By Indication
  - 17.6.2.3. By End-Use
  - 17.6.2.4. By Distribution Channel
17.7. France
- 17.7.1. Pricing Analysis
- 17.7.2. Market Share Analysis, 2023
  - 17.7.2.1. By Product
  - 17.7.2.2. By Indication
  - 17.7.2.3. By End-Use
  - 17.7.2.4. By Distribution Channel
17.8. Spain
- 17.8.1. Pricing Analysis
- 17.8.2. Market Share Analysis, 2023
  - 17.8.2.1. By Product
  - 17.8.2.2. By Indication
  - 17.8.2.3. By End-Use
  - 17.8.2.4. By Distribution Channel
17.9. Italy
- 17.9.1. Pricing Analysis
- 17.9.2. Market Share Analysis, 2023
  - 17.9.2.1. By Product
  - 17.9.2.2. By Indication
  - 17.9.2.3. By End-Use
  - 17.9.2.4. By Distribution Channel
17.10. India
- 17.10.1. Pricing Analysis
- 17.10.2. Market Share Analysis, 2023
  - 17.10.2.1. By Product
  - 17.10.2.2. By Indication
  - 17.10.2.3. By End-Use
  - 17.10.2.4. By Distribution Channel
17.11. Malaysia
- 17.11.1. Pricing Analysis
- 17.11.2. Market Share Analysis, 2023
  - 17.11.2.1. By Product
  - 17.11.2.2. By Indication
  - 17.11.2.3. By End-Use
  - 17.11.2.4. By Distribution Channel
17.12. Singapore
- 17.12.1. Pricing Analysis
- 17.12.2. Market Share Analysis, 2023
  - 17.12.2.1. By Product
  - 17.12.2.2. By Indication
  - 17.12.2.3. By End-Use
  - 17.12.2.4. By Distribution Channel
17.13. Thailand
- 17.13.1. Pricing Analysis
- 17.13.2. Market Share Analysis, 2023
  - 17.13.2.1. By Product
  - 17.13.2.2. By Indication
  - 17.13.2.3. By End-Use
  - 17.13.2.4. By Distribution Channel
17.14. China
- 17.14.1. Pricing Analysis
- 17.14.2. Market Share Analysis, 2023
  - 17.14.2.1. By Product
  - 17.14.2.2. By Indication
  - 17.14.2.3. By End-Use
  - 17.14.2.4. By Distribution Channel
17.15. Japan
- 17.15.1. Pricing Analysis
- 17.15.2. Market Share Analysis, 2023
  - 17.15.2.1. By Product
  - 17.15.2.2. By Indication
  - 17.15.2.3. By End-Use
  - 17.15.2.4. By Distribution Channel
17.16. South Korea
- 17.16.1. Pricing Analysis
- 17.16.2. Market Share Analysis, 2023
  - 17.16.2.1. By Product
  - 17.16.2.2. By Indication
  - 17.16.2.3. By End-Use
  - 17.16.2.4. By Distribution Channel
17.17. Australia
- 17.17.1. Pricing Analysis
- 17.17.2. Market Share Analysis, 2023
  - 17.17.2.1. By Product
  - 17.17.2.2. By Indication
  - 17.17.2.3. By End-Use
  - 17.17.2.4. By Distribution Channel
17.18. New Zealand
- 17.18.1. Pricing Analysis
- 17.18.2. Market Share Analysis, 2023
  - 17.18.2.1. By Product
  - 17.18.2.2. By Indication
  - 17.18.2.3. By End-Use
  - 17.18.2.4. By Distribution Channel
17.19. GCC Countries
- 17.19.1. Pricing Analysis
- 17.19.2. Market Share Analysis, 2023
  - 17.19.2.1. By Product
  - 17.19.2.2. By Indication
  - 17.19.2.3. By End-Use
  - 17.19.2.4. By Distribution Channel
17.20. South Africa
- 17.20.1. Pricing Analysis
- 17.20.2. Market Share Analysis, 2023
  - 17.20.2.1. By Product
  - 17.20.2.2. By Indication
  - 17.20.2.3. By End-Use
  - 17.20.2.4. By Distribution Channel
17.21. Israel
- 17.21.1. Pricing Analysis
- 17.21.2. Market Share Analysis, 2023
  - 17.21.2.1. By Product
  - 17.21.2.2. By Indication
  - 17.21.2.3. By End-Use
  - 17.21.2.4. By Distribution Channel

18. Market Structure Analysis

18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
- 18.3.1. By Regional
- 18.3.2. By Product
- 18.3.3. By Indication
- 18.3.4. By End-Use
- 18.3.5. By Distribution Channel

19. Competition Analysis

19.1. Competition Deep Dive
- 19.1.1. COHERO Health Inc.
  - 19.1.1.1. Overview
  - 19.1.1.2. Product Portfolio
  - 19.1.1.3. Profitability by Market Segments
  - 19.1.1.4. Sales Footprint
  - 19.1.1.5. Strategy Overview
    - 19.1.1.5.1. Marketing Strategy
- 19.1.2. Cognita Labs
  - 19.1.2.1. Overview
  - 19.1.2.2. Product Portfolio
  - 19.1.2.3. Profitability by Market Segments
  - 19.1.2.4. Sales Footprint
  - 19.1.2.5. Strategy Overview
    - 19.1.2.5.1. Marketing Strategy
- 19.1.3. Adherium Limited
  - 19.1.3.1. Overview
  - 19.1.3.2. Product Portfolio
  - 19.1.3.3. Profitability by Market Segments
  - 19.1.3.4. Sales Footprint
  - 19.1.3.5. Strategy Overview
    - 19.1.3.5.1. Marketing Strategy
- 19.1.4. Amiko Digital Health Limited
  - 19.1.4.1. Overview
  - 19.1.4.2. Product Portfolio
  - 19.1.4.3. Profitability by Market Segments
  - 19.1.4.4. Sales Footprint
  - 19.1.4.5. Strategy Overview
    - 19.1.4.5.1. Marketing Strategy
- 19.1.5. Teva Pharmaceuticals Industries Ltd.
  - 19.1.5.1. Overview
  - 19.1.5.2. Product Portfolio
  - 19.1.5.3. Profitability by Market Segments
  - 19.1.5.4. Sales Footprint
  - 19.1.5.5. Strategy Overview
    - 19.1.5.5.1. Marketing Strategy
- 19.1.6. Propeller Health
  - 19.1.6.1. Overview
  - 19.1.6.2. Product Portfolio
  - 19.1.6.3. Profitability by Market Segments
  - 19.1.6.4. Sales Footprint
  - 19.1.6.5. Strategy Overview
    - 19.1.6.5.1. Marketing Strategy
- 19.1.7. Novartis AG
  - 19.1.7.1. Overview
  - 19.1.7.2. Product Portfolio
  - 19.1.7.3. Profitability by Market Segments
  - 19.1.7.4. Sales Footprint
  - 19.1.7.5. Strategy Overview
    - 19.1.7.5.1. Marketing Strategy
- 19.1.8. Pneuma Respiratory Inc.
  - 19.1.8.1. Overview
  - 19.1.8.2. Product Portfolio
  - 19.1.8.3. Profitability by Market Segments
  - 19.1.8.4. Sales Footprint
  - 19.1.8.5. Strategy Overview
    - 19.1.8.5.1. Marketing Strategy
- 19.1.9. 3M Health Care Limited
  - 19.1.9.1. Overview
  - 19.1.9.2. Product Portfolio
  - 19.1.9.3. Profitability by Market Segments
  - 19.1.9.4. Sales Footprint
  - 19.1.9.5. Strategy Overview
    - 19.1.9.5.1. Marketing Strategy
- 19.1.10. AireHealth, Inc.
  - 19.1.10.1. Overview
  - 19.1.10.2. Product Portfolio
  - 19.1.10.3. Profitability by Market Segments
  - 19.1.10.4. Sales Footprint
  - 19.1.10.5. Strategy Overview
    - 19.1.10.5.1. Marketing Strategy